Overview

A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy Subjects

Status:
Completed
Trial end date:
2020-11-16
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the effects of a high-fat meal and of a low-fat meal on the bioavailability of relacorilant in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Corcept Therapeutics
Treatments:
Cortisone